Rapid Fluidics Ltd provides microfluidic design and rapid-prototyping services to life science and biotechnology organizations. The company develops custom microfluidic devices and test cards using a proprietary resin-based 3D printing process that produces complex internal channel geometries. This process enables prototype delivery in as little as 24 hours. Its customers operate in healthcare, diagnostics, medical devices, and industrial sectors, including research labs and multinational pharma firms. Paul Marshall serves as CEO and co-founder.